# Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients

> **NCT00798460** · PHASE4 · TERMINATED · sponsor: **Inje University** · enrollment: 30 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** adefovir
- **DRUG:** clevudine
- **DRUG:** lamivudine

## Key facts

- **NCT ID:** NCT00798460
- **Lead sponsor:** Inje University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2010-06
- **Final completion:** 2010-11
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** could not enroll patients
- **Last updated:** 2011-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00798460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00798460, "Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00798460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*